Innovation in Insulin Affordability and Accessibility
Innovation in Insulin Affordability and Accessibility
Innovation in Insulin Affordability and Accessibility
About us
Our pioneering mentality set the road for biotechnology in Saudi Arabia, and we continue to employ the same attitude in exploring creative techniques to improve patient outcomes today for a better tomorrow. This pushes us to consistently develop novel approaches to illness treatment.
Our mission
Our mission is to provide patients with innovative, cost-effective healthcare anywhere in the middle east. By changing the paradigm of healthcare, we hope to achieve this. Our mission statement outlines our pursuit of long-term, sustainable growth and value delivery to stakeholders. These are the main priorities that direct us toward our objectives.
Our Focus
Insulin biosimilars are biologic drugs that are highly similar to existing insulin products, known as reference insulins. They are developed to treat diabetes and provide an alternative option for patients who may benefit from different formulations, dosing options, or pricing.
Our Team
Our pharmaceutical company is backed by a team with deep international expertise and a legacy of over 100 years of collective experience in the field. Our professionals have held key positions at renowned multinational corporations such as GlaxoSmithKline (GSK) and Eli Lilly, bringing extensive knowledge and proven success to our operations. Their diverse experience across these industry leaders allows us to uphold the highest standards of innovation, quality, and global best practices, ensuring that we continue to push the boundaries of healthcare solutions worldwide. Our team's commitment to excellence and a deep understanding of the pharmaceutical landscape make us a trusted partner in delivering cutting-edge treatments and therapies.
About us
Our pioneering mentality set the road for biotechnology in Saudi Arabia, and we continue to employ the same attitude in exploring creative techniques to improve patient outcomes today for a better tomorrow. This pushes us to consistently develop novel approaches to illness treatment.
Our mission
Our mission is to provide patients with innovative, cost-effective healthcare anywhere in the middle east. By changing the paradigm of healthcare, we hope to achieve this. Our mission statement outlines our pursuit of long-term, sustainable growth and value delivery to stakeholders. These are the main priorities that direct us toward our objectives.
Our Focus
Insulin biosimilars are biologic drugs that are highly similar to existing insulin products, known as reference insulins. They are developed to treat diabetes and provide an alternative option for patients who may benefit from different formulations, dosing options, or pricing.
Partners
In order to achieve the goal of guaranteeing fair healthcare services for all people, we think it is important to use the strength of strategic alliances and teamwork. In addition to creating symbiotic internal R&D capabilities to produce state-of-the-art science, we have also established symbiotic international relationships that enable us to share risks, reduce expenses, increase productivity, hasten development, and broaden our reach.
Our Team
Our pharmaceutical company is backed by a team with deep international expertise and a legacy of over 100 years of collective experience in the field. Our professionals have held key positions at renowned multinational corporations such as GlaxoSmithKline (GSK) and Eli Lilly, bringing extensive knowledge and proven success to our operations. Their diverse experience across these industry leaders allows us to uphold the highest standards of innovation, quality, and global best practices, ensuring that we continue to push the boundaries of healthcare solutions worldwide. Our team's commitment to excellence and a deep understanding of the pharmaceutical landscape make us a trusted partner in delivering cutting-edge treatments and therapies.
About us
Our pioneering mentality set the road for biotechnology in Saudi Arabia, and we continue to employ the same attitude in exploring creative techniques to improve patient outcomes today for a better tomorrow. This pushes us to consistently develop novel approaches to illness treatment.
Our mission
Our mission is to provide patients with innovative, cost-effective healthcare anywhere in the middle east. By changing the paradigm of healthcare, we hope to achieve this. Our mission statement outlines our pursuit of long-term, sustainable growth and value delivery to stakeholders. These are the main priorities that direct us toward our objectives.
Our Focus
Insulin biosimilars are biologic drugs that are highly similar to existing insulin products, known as reference insulins. They are developed to treat diabetes and provide an alternative option for patients who may benefit from different formulations, dosing options, or pricing.
Partners
In order to achieve the goal of guaranteeing fair healthcare services for all people, we think it is important to use the strength of strategic alliances and teamwork. In addition to creating symbiotic internal R&D capabilities to produce state-of-the-art science, we have also established symbiotic international relationships that enable us to share risks, reduce expenses, increase productivity, hasten development, and broaden our reach.
Our Team
Our pharmaceutical company is backed by a team with deep international expertise and a legacy of over 100 years of collective experience in the field. Our professionals have held key positions at renowned multinational corporations such as GlaxoSmithKline (GSK) and Eli Lilly, bringing extensive knowledge and proven success to our operations. Their diverse experience across these industry leaders allows us to uphold the highest standards of innovation, quality, and global best practices, ensuring that we continue to push the boundaries of healthcare solutions worldwide. Our team's commitment to excellence and a deep understanding of the pharmaceutical landscape make us a trusted partner in delivering cutting-edge treatments and therapies.
Why Biosimilars
Why Biosimilars
Safety and Efficacy
Worldwide acceptance
Cost-Effectiveness
Global Impact
Products
Products
Focusing mainly in the Biosimilars products in the following fields
Focusing mainly in the Biosimilars products in the following fields
Diabetes
Anti-Cancer